The Combination of 17-Estradiol and Bisphenol A Weaken their Respective Action

Abstract:

17-Estradiol (E2) and Bisphenol A (BPA) are important endocrine disrupting chemicals (EDCs). In this work, cell proliferation assay using cell cycle analysis method and determination of estrogen receptor α protein was used to investigated the mechanism and effects respectively and in mixture of the two EDCs in stimulating the growth of human breast cancer MCF-7 cell When the concentration of E2 and BPA were 10-12mol/L and 10-8mol/L respectively, E2 and BPA could reduce the express of ERα protein by activated ERα pathway, accelerated the cell cycle, decreased the percentages of cells in G0/1 phase, increased the percentages of cells in S phase at 48 h, and thus promoted the cancer cell growth. However, the combination effect of these two compounds did not induce the growth of cancer cell and the mixture reduced the ratio in S phase compared with E2 or BPA alone, which lead to weakening of the proliferation ability. There was a significant interaction between BPA and E2 and such a weakening effect had not been reported before.

• Periodical: Advanced Materials Research (Volumes 113-116)
• Pages: 2220-2223
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.113-116.2220
• Online since: June 2010
• Authors: Lang Lang, Gaung Ming Zhang, Yu Li
• Keywords: Action Mechanism, Bisphenol A (BPA), Combined Action, E2, Weaken

References

[1] M.V. Maffini, B.S. Rubin, C. Sonnenschein. Endocrine disruptors and reproductive health: The case of bisphenol-A. Molecular and Cellular Endocrinology. Vol. 254-255 (2006), pp.179-186.

DOI: 10.1016/j.mce.2006.04.033

[2] C.A. Richter, L.S. Birnbaum, F. Farabollini. In vivo effects of bisphenol A in laboratory rodent studies. Reproductive Toxicology. Vol. 24 (2007), pp.199-224.

DOI: 10.1016/j.reprotox.2007.06.004

[3] Y.B. Wetherill, B.T. Akingbemi, J. Kanno. In vitro molecular mechanisms of bisphenol A action. Reproductive Toxicology. Vol. 24 (2007), pp.178-198.

DOI: 10.1016/j.reprotox.2007.05.010

[4] A.M. Soto, M.F. Fernandez, M.F. Luizz. Developing a Marker of Exposure to Xenoestrogen Mixtures in Human Serum. Environmental Health Perspectives. Vol. 105(1997), pp.647-654.

DOI: 10.1289/ehp.97105s3647

[5] A.M. Soto, C. Sonnenschein, K.L. Chung. The E-SCREEN Assay as a Tool to Identify Estrogens: An Update on Estrogenic Environmental Pollutants. Environmental Health Perspectives. Vol. 103(1995), pp.113-122.

DOI: 10.2307/3432519

[6] M. Brama, L. Gnessi, S. Basciani. Cadmium induces mitogenic signaling in breast cancer cell by an ERα-dependent mechanism. Molecular and Cellular Endocrinology. Vol. 264 (2007), pp.102-108.

DOI: 10.1016/j.mce.2006.10.013

[7] N. Geffroy, A. Guédin, C. Dacquet, P. Lefebvre. Cell cycle regulation of breast cancer cells through estrogen-induced activities of ERK and Akt protein kinases. Molecular and Cellular Endocrinology. Vol. 237 (2005), pp.11-23.

DOI: 10.1016/j.mce.2005.04.003

[8] S.Y. Choe, S.J. Kim, H.G. Kim. Evaluation of estrogenicity of major heavy metals. The Science of the Total Environment. Vol. 312 (2003), pp.15-21.

DOI: 10.1016/s0048-9697(03)00190-6

[9] J.M. Yi, H.Y. Kwon, J.Y. Cho, Y.J. Lee. Estrogen and hypoxia regulate estrogen receptor alpha in a synergistic manner. Biochemical and Biophysical Research Communications. Vol. 143(2009), pp.1-5.

DOI: 10.1016/j.bbrc.2008.11.142

[10] J.Y. Im, H. Park, K.W. Kang. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells. Chemico-Biological Interactions. Vol. 172 (2008), pp.235-244.

DOI: 10.1016/j.cbi.2008.01.007